517 related articles for article (PubMed ID: 10618612)
1. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Camp RL; Rimm EB; Rimm DL
Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
[TBL] [Abstract][Full Text] [Related]
2. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
3. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
[TBL] [Abstract][Full Text] [Related]
4. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Millis RR; Springall RJ; Hanby AM; Ryder K; Fentiman IS
Cancer; 2002 Apr; 94(8):2307-9. PubMed ID: 12001132
[No Abstract] [Full Text] [Related]
5. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
6. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
7. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma.
Moorman PG; Hamza A; Marks JR; Olson JA
Cancer; 2001 Jun; 91(12):2258-62. PubMed ID: 11413513
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia.
Ibrahim EM; Elkhodary TR; Zekri JM; Bahadur Y; El-Sayed ME; Al-Gahmi AM; Rizvi SA; Hassouna AH; Fawzy EE; Awadalla SS
Asia Pac J Clin Oncol; 2010 Jun; 6(2):130-7. PubMed ID: 20565426
[TBL] [Abstract][Full Text] [Related]
12. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
13. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
[TBL] [Abstract][Full Text] [Related]
14. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
[TBL] [Abstract][Full Text] [Related]
15. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
17. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
18. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
Altinyollar H; Berberoğlu U; Gülben K; Irkin F
J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of lymphangiosis carcinomatosa and malignancy grading in T1/T2-N0 cancers of the breast using 10 or fewer examined axillary lymph nodes].
Stauch G; Szulfer CC; Hilfrich J; Georgii A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):283-8. PubMed ID: 2721890
[TBL] [Abstract][Full Text] [Related]
20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
